What is Dr Reddys Laboratories Ltd (DRREDDY) share price today?

Dr Reddys Laboratories Ltd (DRREDDY) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/DRREDDY for the latest live price, technical analysis, and AI-powered insights.

How to analyse DRREDDY stock?

VestAI provides comprehensive DRREDDY stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Dr Reddys Laboratories Ltd in?

Dr Reddys Laboratories Ltd (DRREDDY) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Dr Reddys Laboratories Ltd

Name: Dr Reddys Laboratories Ltd (DRREDDY) Financial Metrics
Creator: VestAI
License: https://www.vestai.io/terms

DRREDDY

NSE· Healthcare

₹1,176.00

+3.40 (+0.29%)

52W Low · ₹1,101.0052W High · ₹1,414.90

Near 52W Low

Market Cap

₹95636.74L Cr

Volume

18.83L

Prev Close

₹1,180.00

ISIN

INE089A01031

Orion Score

Fundamentals-based quality & risk · not a recommendation

72/100

Quality

Dr Reddys Laboratories Ltd scores 72/100 (Quality) on the Orion Score — strong business quality (77), moderate growth (68), strong balance-sheet safety (79) and fair valuation (50). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.1× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 3/9Altman Z Safe(6.94)Beneish M Clean(-2.51)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

56/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.19x — lean balance sheet

QUALITY

Average

ROCE 12.2% — decent returns

MOMENTUM

Bearish

RSI 39.2 — weak momentum

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q1 FY2027

P/E Ratio: 28.90
ROCE: 12.17%
ROE (1Y): 8.84%
D/E Ratio: 0.19x
OPM: 3.76%
TTM EPS: ₹39.72
Dividend Yield: 70.00%
Qtrly Sales: ₹8,070.50 Cr
Qtrly Profit: ₹443.50 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹7,516.2	₹220.9	1.1%	₹2.65
Q3 2026	₹8,726.8	₹1,209.8	16.4%	₹14.52
Q2 2026	₹8,805.1	₹1,437.2	20.3%	—
Q1 2026	₹8,545.2	₹1,417.8	19.7%	₹17.02
Q4 2025	₹8,506	₹1,593.3	19.1%	₹19.10

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹33,593.3	₹4,285	₹7,916	14.9%
FY 2025	₹32,553.5	₹5,654.4	₹9,667.1	22.1%
FY 2024	₹27,916.4	₹5,568.4	₹8,842.2	23.4%
FY 2023	₹24,587.9	₹4,506.7	₹7,443.1	24.0%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
DRREDDY ★	₹95,637 Cr	28.90	12.17%	8.84%	0.19x	3.76%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,921 Cr	26.18	12.55%	9.93%	0.21x	15.11%
ASTERDMAster DM Quality	₹71,665 Cr	109.91	8.93%	10.07%	0.46x	13.98%
ABBOTINDIAAbbott India Limited	₹59,073 Cr	38.07	36.31%	34.46%	0.04x	27.01%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹49,298.9	₹38,751.8	₹32,185.4	₹29,282.7
Equity	₹33,338.8	₹28,055	₹23,099.1	₹19,052.7
Total Debt	₹4,676.6	₹2,002	₹1,347.2	₹3,384.5
Cash	₹1,465.4	₹710.7	₹577.9	₹1,485.2
Net Debt	₹2,719.1	₹941.6	₹541.1	₹1,603
Working Capital	₹11,972	₹15,201	₹11,840.8	₹8,784.1

Shareholding Pattern

Q1 FY2027

Promoter

29.77%

FII

29.52%

DII

24.16%

Public

16.55%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	29.77% ↑	29.52% ↑	24.16% ↑	16.55% ↓
Q4 FY2026	29.45% ↑	28.81% ↑	23.58% ↓	18.16% ↓
Q3 FY2026	26.64%	22.34% ↓	30.44% ↑	20.33% ↓
Q2 FY2026	26.64%	24.69% ↓	27.99% ↑	20.45% ↓
Q1 FY2026	26.64%	25.33% ↓	26.73% ↑	21.04% ↓
Q4 FY2025	26.64%	25.75% ↓	25.63% ↑	21.69% ↓
Q3 FY2025	26.64%	26.85% ↓	22.89% ↑	23.46% ↓
Q2 FY2025	26.64%	27.53%	21.48%	24.2%

Corporate Actions

Ex-Date	Action	Details
2026-07-10	DIVIDEND	Dividend - Rs 8 Per Share

Funds Holding This Stock

186 mutual fund schemes

ICICI Prudential Nifty Pharma Index Fund Direct GrowthICICI_PRUDENTIAL

8.89%

₹12 Cr

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI_PRUDENTIAL

7.70%

₹497 Cr

DSP Nifty Healthcare Index Fund Direct GrowthDSP

7.62%

₹2 Cr

Nippon India Pharma Fund Direct GrowthRELIANCE

6.72%

₹580 Cr

Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

5.41%

₹1 Cr

Bandhan Healthcare Fund Direct GrowthIDFC

5.03%

₹16 Cr

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct GrowthEDELWEISS

4.68%

₹8 Cr

Mirae Asset Healthcare Fund Direct GrowthMIRAE_ASSET

4.27%

₹132 Cr

Tata India Pharma & Healthcare Fund Direct GrowthTATA

4.02%

₹56 Cr

ITI Pharma and Healthcare Fund Direct GrowthITI

3.98%

₹9 Cr

Analyse DRREDDY with Orion AI

Ask: "Is Dr Reddys Laboratories Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Dr Reddys Laboratories Ltd (DRREDDY) Stock

Dr Reddys Laboratories Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE089A01031. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.